MRK logo

MRK Merck & Co., Inc.

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$133.72
+0.91 (+0.69%)

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This divisio…

Market Cap: $329.65Bwww.merck.com

Price

$133.72-14.53%
$132.81$140.69$148.57$156.45
Aug 25Nov 20

Social Signal Score

49
5d
48
9 mentions
-6.7%
30d
49
55 mentions
-8.0%
60d
49
93 mentions
-9.7%
90d
51
131 mentions
-11.2%
marketaux: 8 · news: 86 · rss: 32 · 4chan: 3 · finnhub: 1 · podcast: 1

Analyst Ratings

38 analysts
Buyconsensus
Strong Buy 0Buy 26Hold 11Sell 1Strong Sell 0
Avg price target$159.45+19.2%
Low $105Median $165High $180
Current Consensus

52-week range

$94.97$156.45
Last close
$133.72
Off 52w high
-14.5%
200-day average
$129.22
vs 200-day
+3.5%

Revenue

$18.09B+78.79%
$9.35B$12.26B$15.17B$18.09B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$8.93
$8.87–$9.02
17 analysts
FY2026
$2.79-69% YoY
$2.51–$3.00
14 analysts
FY2027
$8.90+219% YoY
$8.44–$9.36
14 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert Davis
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
74,000
Beta
0.22
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.70
www.merck.com